Engegliflozin Tablets (strength: 10 mg, MAH: Hefei Guogao Pharma) technically transferred and manufactured in Huayi has been approved for marketing by the NMPA, which marks another in-depth expansion of Huayi in the field of customer service!

Engegliflozin Tablets

Engegliflozin is a new oral selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor, which is suitable for improving glycemic control in patients with type 2 diabetes mellitus in conjunction with dietary control and exercise. It can also be used in combination with other hypoglycemic agents for synergistic effects, and also has significant benefits in the treatment of heart failure and protection of the heart and kidneys. Its hypoglycemic mechanism of action does not depend on insulin secretion, thus the risk of hypoglycemia is lower. It can also increase calorie consumption and urinary excretion of sugar, thus reducing body weight, and it has a mild diuretic effect, which can reduce blood pressure. As a drug with new mechanism, Engegliflozin brings better choices for the treatment of patients with type 2 diabetes mellitus.

With superb technical strength and production capacity, Huayi has won the trust of customers. We always adhere to strict standards and requirements to ensure compliance of the drug production process and controllability of drug quality, and fully satisfy our customers’ strict demands for drug production. The close strategic cooperation with Hefei Gogao Pharmaceutical is based on common goals and trust, and the products have been approved by the NMPA for marketing. Looking forward to the future, we are full of expectations and are willing to further broaden the field of cooperation with Hefei Gogao Pharmaceutical and jointly promote the sustainable development and progress of the pharmaceutical industry.

Huayi will continue to dedicate itself to pharmaceutical field, always adhering to provide customers with high-efficient, high-quality, cost-controllable and trustworthy R & D and manufacture services. We are committed to empowering more partners to realize win-win development and create a better future together!